Xia Kang

1.8k citations
63 papers · 1.2k indexed · h-index 18

Xia Kang

59 papers receiving 1.2k citations

Peers

Xia Kang
Comparison fields: 5 of 125
  • Orthopedics and Sports Medicine 323
  • Cancer Research 174
  • Rehabilitation 65
  • Rheumatology 109
  • Surgery 233
Replace Shinji Kitamura with:
Shinji Kitamura Japan
Egon Perilli Australia
Ryo Fujita Japan
Daquan Liu China
Yong Yang China
Vickie Shim New Zealand
Ci Li China
Haisheng Yang China
Kai‐Rong Qin China
Xia Kang relative to Shinji Kitamura Japan Shinji Kitamura's profile →
Citations per field
00.5×8.1×
Shinji Kitamura · 1×
Citations per year

Countries citing papers authored by Xia Kang

Since Specialization
Citations

This map shows the geographic impact of Xia Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Kang more than expected).

Fields of papers citing papers by Xia Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Kang. The network helps show where Xia Kang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xia Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xia Kang Line = papers co-authored together Xia Kang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20260
2 20252
3 20251
4 20254
5 20242
6 20241
7 20241
8 20242
9 20235
10 20238
11 20233
12 202036
13 2019116
14 20196
15
Effect of comprehensive nursing intervention on therapy and life quality of patients with breast cancer
20172
16 201719
17 20147
18 201312
19
Effects of Danhong injection on expression of ICAM-1 in rat kidneys with ischemia-reperfusion injury after renal transplantation
20101
20 19961

About Xia Kang

Xia Kang is a scholar working on Orthopedics and Sports Medicine, Rehabilitation and Nuclear and High Energy Physics, having authored 63 papers that have together received 1.2k indexed citations. Recurring topics across this work include Tendon Structure and Treatment (12 papers), Particle Accelerators and Free-Electron Lasers (8 papers), Particle accelerators and beam dynamics (7 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Shoulder Injury and Treatment (5 papers), Sports injuries and prevention (5 papers), Immune cells in cancer (4 papers) and Muscle Physiology and Disorders (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (323 citations), Cancer Research (174 citations) and Rehabilitation (65 citations). Xia Kang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Kanglai Tang, Yunjiao Wang, Gang He, Youxing Shi, Mei Zhou, Xuting Bian, Hong Tang, Huibin Sun, Jingtong Lyu and Jiqiang Zhang. Their work appears in journals such as Signal Transduction and Targeted Therapy, Frontiers in Immunology, FEBS Letters, Medicine and Cell Communication and Signaling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026